Abiopharma

New Form 8-K - Neuraxis, INC Filed: 2025-07-03 AccNo: 0001641172-25-017723 Size: 440 KB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits